Dataset opportunity
Fuhrmann — Public Procurement Dataset Opportunity
Moderate public procurement dataset held by Fuhrmann, usable for Tender Intelligence and Document Intelligence.
Score
47.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
License
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Procurement Analytics Market = $6.49B in 2025, CAGR 22.88%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Public Procurement Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
Medium
Accessibility
Partial
Legal
Owned by the company — licensing rights to clarify
Buyer persona
GovTech & procurement-intelligence vendors
Fuhrmann holds a Public Procurement Dataset in Text modality, comprising business records, procurement data, and industrial information. This data is specifically structured for Tender Intelligence applications, enabling AI-driven analysis of tender specifications, competitor bidding patterns, and pricing strategies within the specialized healthcare market.
The business value is substantial, operating within the Global Procurement Analytics Market, which was valued at $6.49 billion in 2025 and is projected to grow at a CAGR of 22.88%. While access involves navigating medical device regulatory constraints (ISO 13485) and proprietary manufacturing protocols, this complexity ensures the data's rarity and strategic worth. The high market growth justifies the investment needed to access these unique insights for a competitive advantage. ⚠ Diligence (valuable data, access to negotiate): Medical device regulatory constraints (ISO 13485); Proprietary manufacturing and sterilization protocols; B2B supply chain data involving clinical partners · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Fuhrmann holds proprietary data on the composition and consumption of medical sets, a critical asset for the healthcare procurement sector. This dataset directly enables tender intelligence and predictive analytics for GovTech and procurement-intelligence vendors, allowing them to anticipate demand in a global market projected to hit $6.49B by 2025. The combination of procurement records with product and quality data creates a uniquely rich signal for modeling future purchasing needs.
See dimension details ↓- Dataset Specificity78
dominant 'procurement', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity46
proprietary domain data (open lowers rarity)
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness62
API/open (current)
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Tender Intelligence
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is exceptionally high, driven by the rapid expansion of the **Global Procurement Analytics Market** at a forecasted **CAGR** of **22.88%**.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility56
open/API access
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility66
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 evidence types, 4 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
ownership=company_owned, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
surplus=medium — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit58
⚠ review — This company's core business is manufacturing and distributing physical medical products, not selling data or intelligence, but the 'Public Procurement Dataset' mentioned in the prompt appears to be a misunderstanding or related to a different entity. Issues: The company Fuhrmann GmbH at fuhrmann.de is a manufacturer of medical supplies like dressing materials and single-use instruments.; Its core business is producing and selling physical goods to clinics and medical wholesalers, not data or software.; There is no evidence on their website or in search results that they hold or sell a 'Public Procurement Dataset'. This appears to be a misattribution. A differe; The company does not fit the ideal profile of holding valuable 'dormant data' as a by-product; its operational data would likely be related to manufacturing and
- Deep Qualification80
✓ pass — Fuhrmann is a medical device manufacturer and service provider, making the existence of a public procurement dataset plausible as a by-product of its sales to hospital purchasing groups; however, data ownership is likely mixed and licensing rights are unclear.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Downloads / exports
The company provides downloadable assets, likely detailed product catalogs or technical specifications, which are essential for enriching tender documents and building comprehensive item masters.
business_records
Fuhrmann's business records detail a comprehensive range of single-use surgical instruments, providing the specific product context and domain ontology needed to accurately classify and analyze procurement activities.
Industrial data
Evidence of a certified quality management system points to documented manufacturing and sterilization process data, a valuable signal for modeling supplier risk and compliance in regulated public tenders.
Procurement / tenders
The core dataset contains text records detailing the composition and consumption patterns of medical sets, enabling powerful demand forecasting and tender intelligence applications for healthcare providers.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Fuhrmann Public Procurement — a Moderate public procurement dataset (Text modality) in the healthcare domain. Primary AI use-case: Tender Intelligence. Market signal: Global Procurement Analytics Market = $6.49B in 2025, CAGR 22.88% (source: Precedence Research).. Investment score 47.5/100 (confidence 0.56). Recommended action: License.
From the marketplace
Explore live data opportunities
Medserena — Medical Imaging Dataset Opportunity
View opportunity →healthcareMedasil — Regulatory Records Dataset Opportunity
View opportunity →healthcareAbilitypharma — Medical Imaging Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- 5 Mistakes That Drive Buyers Away3 min read
- Why Buy External Data?3 min read
- Buying Data Without Mistakes3 min read